← Browse by Condition
Medical Condition

atopic dermatitis

Total Trials
20
Recruiting Now
20
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for atopic dermatitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — atopic dermatitis Clinical Trials

How many clinical trials are currently recruiting for atopic dermatitis?
ClinicalMetric currently tracks 20 actively recruiting clinical trials for atopic dermatitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 20. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for atopic dermatitis?
atopic dermatitis research spans Phase 1 (4 trials), Phase 2 (4 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a atopic dermatitis clinical trial?
Eligibility criteria for atopic dermatitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
4
Phase 2
4
Phase 3
1
Phase 4
1
Top Sponsors
Chengdu Zenitar Biomedical Technology Co., Ltd 1 trial
Makati Medical Center 1 trial
Swiss Society of Dermatology and Venereology 1 trial
Novartis Pharmaceuticals 1 trial
Brexogen Inc. 1 trial

Recruiting Clinical Trials

NCT07193589 Phase 2
Recruiting
A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
Enrollment
111 pts
Location
China
Sponsor
Chengdu Zenitar Biomedical Tec...
View Trial →
NCT07183423
Recruiting
Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction
Enrollment
26 pts
Location
Philippines
Sponsor
Makati Medical Center
View Trial →
NCT05819463
Recruiting
Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
Enrollment
700 pts
Location
Switzerland
Sponsor
Swiss Society of Dermatology a...
View Trial →
NCT06947993 Phase 2
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Enrollment
224 pts
Location
United States, Argen...
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06055361 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Enrollment
45 pts
Location
United States
Sponsor
Brexogen Inc.
View Trial →
NCT00605878
Recruiting
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Enrollment
530 pts
Location
United States
Sponsor
National Human Genome Research...
View Trial →
NCT06390878
Recruiting
Nationwide Research on the Rewilding of Kindergarten Yards
Enrollment
320 pts
Location
Finland
Sponsor
Natural Resources Institute Fi...
View Trial →
NCT06765005 Phase 1, Phase 2
Recruiting
IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
Enrollment
24 pts
Location
China
Sponsor
Shanghai Mabgeek Biotech.Co.Lt...
View Trial →
NCT06547372
Recruiting
Dietary Intervention on Atopy
Enrollment
110 pts
Location
Singapore
Sponsor
National University of Singapo...
View Trial →
NCT06116526 Phase 4
Recruiting
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Enrollment
30 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT07014007
Recruiting
Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
Enrollment
105 pts
Location
Mauritius
Sponsor
Pierre Fabre Dermo Cosmetique
View Trial →
NCT04240522
Recruiting
Prospective Longitudinal Observational Research in Atopic Dermatitis
Enrollment
1,000 pts
Location
Switzerland
Sponsor
University of Zurich
View Trial →
NCT07250997
Recruiting
PALLAS Laser for Skin Diseases
Enrollment
50 pts
Location
Hungary
Sponsor
Szeged University
View Trial →
NCT05938478
Recruiting
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Enrollment
900 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT07629778 Phase 1, Phase 2
Recruiting
HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Enrollment
156 pts
Location
China
Sponsor
Hangzhou Highlightll Pharmaceu...
View Trial →
NCT06311682 Phase 3
Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Enrollment
195 pts
Location
United States, Belgi...
Sponsor
LEO Pharma
View Trial →
NCT07444008
Recruiting
Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete
Enrollment
140 pts
Location
Russia
Sponsor
NovoNatum Ltd
View Trial →
NCT00177268
Recruiting
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Enrollment
200 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT06182436
Recruiting
Virtual Reality for Pain Management During Dupilumab Injection
Enrollment
98 pts
Location
Canada
Sponsor
St. Justine's Hospital
View Trial →
NCT06082323 Phase 1
Recruiting
A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
Enrollment
127 pts
Location
China
Sponsor
Leadingtac Pharmaceutical (Sha...
View Trial →

Related Conditions

eczema (3) psoriasis (2) xerosis (1) contact dermatitis (1) microbial colonization (1) asthma in children (1) allergy (1) cognitive change (1) respiratory infection (1) nature human (1) atopic (1) allergic diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology